Back
MAX S&P 500 4X Leveraged ETN Vs. Aligos Therapeutics Industry Stock Comparison
Sell
45
SPYU
MAX S&P 500 4X Leveraged ETN
Last Price:
$49.74
Seasonality Move:
--
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
45
MAX S&P 500 4X Leveraged ETN (SPYU)
is a Sell
Is MAX S&P 500 4X Leveraged ETN a Buy, Sell or Hold?
-
The current MAX S&P 500 4X Leveraged ETN [SPYU] share price is $49.82. The Score for SPYU is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
SPYU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SPYU Stock Price Chart
What is MAX S&P 500 4X Leveraged ETN's stock price today?
-
The MAX S&P 500 4X Leveraged ETN share price today is $49.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPYU is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $41.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
SPYU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 45.73 | Sell |
Chaikin Money Flow: | 266923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.95 - 54.53) | Sell |
Bollinger Bands (100): | (41.7 - 51.8) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 73.75 | Buy |
Chaikin Money Flow: | -154898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.72 - 37.64) | Buy |
Bollinger Bands (100): | (6.81 - 25.85) | Buy |
SPYU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.46 | Sell |
20-day SMA: | 52.48 | Sell |
50-day SMA: | 50.5 | Sell |
200-day SMA: | 42.81 | Buy |
8-day EMA: | 50.81 | Sell |
20-day EMA: | 51.43 | Sell |
50-day EMA: | 50.27 | Sell |
200-day EMA: | 23.41 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.54 | Buy |
20-day SMA: | 33.12 | Buy |
50-day SMA: | 21.28 | Buy |
200-day SMA: | 16.61 | Buy |
8-day EMA: | 38.79 | Buy |
20-day EMA: | 33.47 | Buy |
50-day EMA: | 25.09 | Buy |
200-day EMA: | 18.34 | Buy |
MAX S&P 500 4X Leveraged ETN Earnings Growth & SPYU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
MAX S&P 500 4X Leveraged ETN Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |